Literature DB >> 10828049

The duffy-binding-like domain 1 of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a heparan sulfate ligand that requires 12 mers for binding.

A Barragan1, V Fernandez, Q Chen, A von Euler, M Wahlgren, D Spillmann.   

Abstract

The Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), present on the surfaces of parasitized red blood cells (pRBC), mediates rosetting, a virulent phenotype. Here, we show that pRBC specifically bind heparan sulfate (HS) and heparin onto their surfaces and that the rosetting ligand PfEMP1 specifically adheres to heparin-Sepharose when extracted from the surfaces of radioiodinated infected RBC. An analysis of the binding properties of the different regions of PfEMP1 provides evidence that the Duffy-binding-like domain-1 (DBL-1) is the predominant ligand involved in HS and heparin binding. Soluble DBL-1 requires a minimal heparin fragment size of a 12-mer ( approximately 4 kd) for binding and is critically dependent on N-sulfation. A 12-mer is also the minimal heparin fragment that disrupts naturally formed rosettes. DBL-1 binds specifically to erythrocytes and also to HS from endothelial cells and human aorta but not to chondroitin sulfate A, suggesting that different PfEMP1s mediate adhesion to distinct glycosaminoglycans in individual malaria parasites. Present data suggest that HS on endothelial cells may also be involved in the sequestration of pRBC. Elucidation of these binding mechanisms opens up new possibilities for therapeutic strategies targeting adhesive interactions of pRBC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828049

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Low anticoagulant heparin disrupts Plasmodium falciparum rosettes in fresh clinical isolates.

Authors:  Anna M Leitgeb; Karin Blomqvist; Fidelis Cho-Ngwa; Moses Samje; Peter Nde; Vincent Titanji; Mats Wahlgren
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

Review 2.  Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies.

Authors:  Miloni Thakkar; Brijesh S
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

3.  Inhibition of adhesion of Plasmodium falciparum-infected erythrocytes by structurally defined hyaluronic acid dodecasaccharides.

Authors:  W Chai; J G Beeson; H Kogelberg; G V Brown; A M Lawson
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

4.  Structure of a Plasmodium falciparum PfEMP1 rosetting domain reveals a role for the N-terminal segment in heparin-mediated rosette inhibition.

Authors:  Alexandre Juillerat; Anita Lewit-Bentley; Micheline Guillotte; Stéphane Gangnard; Audrey Hessel; Bruno Baron; Inès Vigan-Womas; Patrick England; Odile Mercereau-Puijalon; Graham A Bentley
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

5.  Short-chain aliphatic polysulfonates inhibit the entry of Plasmodium into red blood cells.

Authors:  Robert Kisilevsky; Ian Crandall; Walter A Szarek; Shridhar Bhat; Christopher Tan; Lee Boudreau; Kevin C Kain
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  CR1 Knops blood group alleles are not associated with severe malaria in the Gambia.

Authors:  P A Zimmerman; J Fitness; J M Moulds; D T McNamara; L J Kasehagen; J Alexandra Rowe; A V S Hill
Journal:  Genes Immun       Date:  2003-07       Impact factor: 2.676

7.  Plasmodium falciparum BAEBL binds to heparan sulfate proteoglycans on the human erythrocyte surface.

Authors:  Kyousuke Kobayashi; Kentaro Kato; Tatsuki Sugi; Hitoshi Takemae; Kishor Pandey; Haiyan Gong; Yukinobu Tohya; Hiroomi Akashi
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

8.  Characterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers.

Authors:  Darren R Krause; Michelle L Gatton; Sarah Frankland; Damon P Eisen; Michael F Good; Leann Tilley; Qin Cheng
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

9.  Growth-inhibitory effect of heparin on Babesia parasites.

Authors:  Sabine Bork; Naoaki Yokoyama; Yuzuru Ikehara; Sanjay Kumar; Chihiro Sugimoto; Ikuo Igarashi
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

Review 10.  Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications.

Authors:  J Alexandra Rowe; Antoine Claessens; Ruth A Corrigan; Mònica Arman
Journal:  Expert Rev Mol Med       Date:  2009-05-26       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.